Published in Am Heart J on April 01, 1982
The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study. Pulm Pharmacol Ther (2007) 1.61
Drug treatment of heart failure. Br Heart J (1985) 0.84
The temporal hormesis of drug therapies. Dose Response (2006) 0.80
The future role of inotropic drugs. Drugs (1986) 0.79
For the love of paradox: from neurobiology to pharmacology. Behav Pharmacol (2011) 0.75
Long-term studies with xamoterol in heart failure. Br J Clin Pharmacol (1989) 0.75
Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation (1982) 3.23
Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med (1992) 2.54
Infarct scar: a dynamic tissue. Cardiovasc Res (2000) 2.21
Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents. Circulation (1989) 2.16
Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res (1989) 2.14
Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol (1995) 2.07
Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res (1993) 2.04
Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res (1988) 2.02
MAP, an expert system for multiple pairwise linkage analysis. Ann Hum Genet (1989) 1.99
Ethnic differences in stroke mortality between non-Hispanic whites, Hispanic whites, and blacks. The National Longitudinal Mortality Study. Stroke (1994) 1.85
Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res (1990) 1.83
Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res (1991) 1.80
Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res (1994) 1.78
Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol (1994) 1.68
Fibrillar collagen and remodeling of dilated canine left ventricle. Circulation (1990) 1.55
Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol (1993) 1.49
Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res (1988) 1.48
The case against thiomersal. Lancet (1991) 1.45
Patterns of myocardial fibrosis. J Mol Cell Cardiol (1989) 1.41
Myocardial remodeling and pathologic hypertrophy. Hosp Pract (Off Ed) (1991) 1.40
Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo. Am Heart J (1982) 1.39
Religiosity and attitudes about abortion. Psychol Rep (2000) 1.39
Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res (1989) 1.38
A centromere map of the X chromosome from trisomies of maternal origin. Ann Hum Genet (1990) 1.37
Collagen and the myocardium: fibrillar structure, biosynthesis and degradation in relation to hypertrophy and its regression. Mol Cell Biochem (1990) 1.32
Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovasc Res (1997) 1.31
Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium. Circ Res (1990) 1.27
Connective tissue and the heart. Functional significance and regulatory mechanisms. Cardiol Clin (2000) 1.24
Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease. J Am Coll Cardiol (1993) 1.22
Intraaortic balloon counterpulsation. A review of physiological principles, clinical results, and device safety. Ann Thorac Surg (1974) 1.20
Direct extraction and estimation of collagenase(s) activity by zymography in microquantities of rat myocardium and uterus. Clin Biochem (1993) 1.20
Contribution of ventricular remodeling to pathogenesis of heart failure in rats. Am J Physiol Heart Circ Physiol (2001) 1.18
Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. Am J Cardiol (1993) 1.17
Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc Res (1993) 1.16
Myocardial matrix metalloproteinase(s): localization and activation. Mol Cell Biochem (1993) 1.14
Cardiac myocyte necrosis induced by angiotensin II. Circ Res (1991) 1.13
Temporal evaluation of left ventricular remodeling and function in rats with chronic volume overload. Am J Physiol (1996) 1.13
Cardiopulmonary exercise testing in congestive heart failure. Am J Cardiol (1988) 1.13
Increase in leg blood-flow by normovolaemic haemodilution in intermittent claudication. Lancet (1979) 1.12
Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results. Circulation (1983) 1.12
Reactive and reparative myocardial fibrosis in arterial hypertension in the rat. Cardiovasc Res (1992) 1.12
Antiparallel polypurine phosphorothioate oligonucleotides form stable triplexes with the rat alpha1(I) collagen gene promoter and inhibit transcription in cultured rat fibroblasts. Nucleic Acids Res (1997) 1.11
Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J Mol Cell Cardiol (1996) 1.10
Echocardiographic patterns of myocardial fibrosis in hypertensive patients: endomyocardial biopsy versus ultrasonic tissue characterization. J Am Soc Echocardiogr (1997) 1.09
Targeting pathological remodeling: concepts of cardioprotection and reparation. Circulation (2000) 1.08
Contractile mechanics and interaction of the right and left ventricles. Am J Cardiol (1981) 1.07
Myocardial oxygen consumption: the role of wall force and shortening. Am J Physiol (1977) 1.07
Alterations in myocardial collagen content affect rat papillary muscle function. Am J Physiol Heart Circ Physiol (2000) 1.07
Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis. Hypertension (1996) 1.07
Muscle fiber orientation and connective tissue content in the hypertrophied human heart. Lab Invest (1982) 1.06
Cardiopulmonary exercise testing for evaluation of chronic cardiac failure. Am J Cardiol (1985) 1.06
Myocardial collagen remodeling in pressure overload hypertrophy. A case for interstitial heart disease. Am J Hypertens (1989) 1.06
Monitoring tissue repair and fibrosis from a distance. Circulation (1997) 1.06
Static anisotropic elastic properties of the aorta in living dogs. Circ Res (1969) 1.04
Fibrosis-induced reduction of endomyocardium in the rat after isoproterenol treatment. Circ Res (1989) 1.04
The pericardium and ventricular interaction, distensibility, and function. Am J Physiol (1980) 1.04
Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone. J Mol Cell Cardiol (1995) 1.04
Myocardial hypertrophy in Macaca fascicularis. Structural remodeling of the collagen matrix. Lab Invest (1987) 1.03
Myocardial fibrosis and pathologic hypertrophy in the rat with renovascular hypertension. Am J Cardiol (1990) 1.03
Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovasc Res (1994) 1.02
Determination of aerobic capacity and the severity of chronic cardiac and circulatory failure. Circulation (1987) 1.02
Static elastic properties of the left coronary circumflex artery and the common carotid artery in dogs. Circ Res (1970) 1.02
Air, methylcellulose, sodium hyaluronate and the corneal endothelium. Endothelial protective agents. Eye (Lond) (1987) 1.00
Hepatitis B core antigen antibody as an indicator of a low grade carrier state for hepatitis B virus in a Saudi Arabian blood donor population. Transfus Sci (1997) 0.99
Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts. Mol Cell Biochem (1996) 0.98
Myocardial fibrosis associated with aldosterone or angiotensin II administration: attenuation by calcium channel blockade. J Mol Cell Cardiol (1998) 0.98
Inadequate collagen tethers in dilated cardiopathy. Am Heart J (1988) 0.98
Structural vs. contractile protein remodeling and myocardial stiffness in hypertrophied rat left ventricle. J Mol Cell Cardiol (1988) 0.98
Inhibition of tissue repair by spironolactone: role of mineralocorticoids in fibrous tissue formation. Mol Cell Biochem (1998) 0.97
Angiotensin-converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone. J Lab Clin Med (1993) 0.97
Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation (1991) 0.97
Aldosterone and spironolactone in heart failure. N Engl J Med (1999) 0.96
Evidence and quantitation of left ventricular systolic resistance. Am J Physiol (1985) 0.96
Is topical haloperidol a useful glaucoma treatment? Br J Ophthalmol (1986) 0.96
Triple helix-forming oligonucleotide corresponding to the polypyrimidine sequence in the rat alpha 1(I) collagen promoter specifically inhibits factor binding and transcription. J Biol Chem (1996) 0.96
Identification of high risk subsets of acute myocardial infarction. Derived from the myocardial infarction research units cooperative study data bank. Am J Cardiol (1978) 0.96
Amrinone in the treatment of chronic cardiac failure. J Am Coll Cardiol (1984) 0.95
Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure. Circulation (1982) 0.95